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PreviewsMovin’ on up: Adipocytes become
regulators of nutrient homeostasis
By locally infecting epididymal adipocytes of obese diabetic mice with the uncoupling protein-1 transgene, Yamada et al.
(2006 [this issue of Cell Metabolism]) unexpectedly induce leptin sensitivity with hypophagia and improvement in abnormal
glucose and lipid abnormalities.Until the discovery of leptin, fat tissuewas
regarded as a passive fuel storage and
dispensing organ controlled by remotely
derived hormones and neurotransmit-
ters. Recognition of the actions of leptin,
together with the discovery of other hor-
mones in adipocytes, elevated fat to the
status of a versatile endocrine gland. Now
a report by Yamada et al. in this issue of
Cell Metabolism seems to enhance further
thekey role of adipose tissueasa regulator
of feeding and fuel metabolism.
Briefly, the Japanese team wished to
determine if a local reduction of adipo-
cyte fat content of obese diabetic mice
would reverse the obesity-related insen-
sitivity to leptin and insulin. Since hyper-
leptinemia can reduce intracellular adipo-
cyte fat content by enhancing uncoupled
fatty oxidation and dissipating the energy
as heat (Orci et al., 2004), they injected
adenovirus containing the cDNA of un-
coupling protein-1 (UCP-1) into the epi-
didymal fat pads in the hope of inducing
localized fat depletion. UCP-1 was ex-
pressed only in epididymal adipocytes
surrounding the injection site and only at
low levels. Nevertheless, the food intake
of the injected mice declined, and their
metabolic abnormalities improved in ex-
cess of that caused by food restriction
in uninjected control mice. The hypo-
phagia was associated with downregula-
tionof theorexigenicneuropeptideY (NPY)
and upregulation of the anorexigenic
precursor neuropeptide, proopiomelano-
cortin (POMC), andwas abolishedby sur-
gical deafferentation of the fat pad and
by the neurotoxin, capsaicin. The hypo-
phagia could not be duplicated in db/db
mice with nonfunctioning leptin recep-
tors. Endogenous leptin levels in UCP-
1-injected mice were reduced by 50%,
and the anorectic response to exoge-
nous leptin was enhanced, evidence of
a dramatic reduction of leptin resistance.
Collectively, these findings suggested
that the hypophagia was mediated by
a neurotransmitted substance that in-
creases hypothalamic sensitivity to leptinCELL METABOLISM 3, 147–151, MARCH 2006Figure 1. A hypothetical mechanism by which UCP-1-expressing white adipocytes might regulate overall ca-
loric intake and metabolism in obese diabetic mice
A) Adenovirus-UCP-1 cDNA injection into an epididymal fat pad induces local UCP-1 expression.
B) An unidentified adipocyte factor, possibly OEA, is induced. Two hypothalamic appetite-regulating targets of
leptin action, NPY and POMC, are sensitized via afferent nerves mediating hypophagia.
C) Humoral action by the same factor sensitizes the peripheral targets of insulin action via direct, leptin-inde-
pendent action. If, as depicted here, OEA should be the unidentified factor, as a PPAR-a ligand its metabolic
actions would alleviate lipid-induced insulin resistance and improve glucose and lipid parameters by enhanc-
ing fatty-acid oxidation in liver and muscle. (LR = leptin receptor.)
Figure by Kay McCorkle.(Figure 1B), conceivably by upregulating
leptin receptor or reducing suppressor
of cytokine signaling (SOCS) 3.
The second observed effect of UCP-1
fat pad expression in obese diabetic
mice was an improvement in blood glu-
cose, insulin, triglyceride and fatty-acid
levels, glucose tolerance, and insulin sen-
sitivity (Figure 1C). It was notmediated by
leptin receptors since it occurred indb/db
mice. Nor was it neurotransmitted since it
was not abolished by surgical or pharma-
cologic ablation of the afferent nerve from
the fat pad. Therefore, it must have been
mediated by a leptinomimetic hormone
that acts independently of leptin receptors.ª2006 ELSEVIER INC.Can this combination of neurotransmit-
ted, leptin-dependent, anorectic action
and hormonally mediated, leptin-inde-
pendent, metabolic effects be caused
byasingleUCP-1-stimulated factor pres-
ent in epididymal fat? Increased adipo-
nectin might induce both hypophagia
and metabolic improvement, but it was
not changed by fat pad expression of
UCP-1. A decline in TNF-a or resistin
might improve metabolism but would
not be predicted to potentiate leptin-in-
duced hypophagia. The unsaturated
fatty-acid amide hormone, oleoylethano-
lamide (OEA), is a less familiar candidate
factor that has both neurotransmitted147
P R E V I E W Sanorectic effects (Rodriguez de Fonseca
et al., 2001) and leptin-independent hu-
moral effects on peripheral metabolism.
It is a peroxisome proliferator-activated
receptor-a (PPAR-a) ligand that requires
this nuclear receptor for its anorectic ac-
tion (Fu et al., 2003), but there is evidence
of neurotransmission via the transient po-
tential vanilloid-1 (TRPV-1) receptor
(Wang et al., 2005). TRPV-1 receptors
can be activated by temperature eleva-
tions (Chung et al., 2003), such as might
occur near UCP-1-expressing adipo-
cytes. Like leptin, they reduce hyperdo-
paminergia, a cause of hyperphagia
(Szczypka et al., 2000; Krugel et al.,
2003), which couldmean that they poten-
tiate leptin action. Finally, OEA-induced
PPAR-a activation in liver and muscle
could also account for the leptin-inde-
pendent, humorally induced, metabolic
improvement (Figure 1C).
While the mechanisms underlying the
effects observed by Yamada et al.
(2006) remain to be elucidated, the study
nevertheless clearly raises the possibility
that some white adipocytes possess the
equipment to regulate both caloric intake
and peripheral nutrient metabolism. If so,
identification of these factors involvedPancreatic b cells:
Responding to the m
In a recent issue of Developmental Cell
pancreatic b cells do not produce a base
b cells by local capillary endothelial ce
production.
Endocrine cells must sense molecules in
the bloodstream and secrete others in
response, all of which is enabled by prox-
imity to the vasculature. Establishing
and maintaining appropriate interactions
with the endothelium are therefore cru-
cial for endocrine gland function. Such
interactions are likely to be specific for
different tissues: consider the fine capil-
laries in a pancreatic islet compared to
the large, hepatic sinusoidal endothe-
lium. Indeed, certain endocrine cells pro-
mote local vascular development by
secreting one of the common vascular
endothelial growth factors (VEGFs) (Lam-
mert et al., 2003), while other endocrine
148might lead to novel therapeutic interven-
tions to prevent the metabolic syndrome,
which now afflicts 39% of Americans
(Ford, 2005). In any case, at a clinical
level, a dominant role of fat tissue in
nutrient homeostasis is supported by
the fact that patients without adipocytes
(congenital generalized lipodystrophy)
develop both hyperphagia and severe
metabolic syndrome and that both re-
spond to leptin replacement therapy
(Oral et al., 2002) with significant im-
provement.
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ther, the matrix is provided to a subset of
helps promote optimal levels of insulin
extracellular matrix produced by endo-
thelial cells in the functions of pancreatic
b-endocrine cells.
The extracellular matrix (ECM) con-
sists of a meshwork of proteins that re-
side outside of cells. For epithelial cells
with apical (secretory) and basal sur-
faces, the basal ECM defines the ‘‘base-
ment membrane,’’ which provides an
adherent substratum and promotes cell
differentiation. Most epithelial cells pro-
duce, or are capable of producing, their
own basement membrane. Disruption
of the epithelial basement membrane oc-
curs during organogenesis, tissue regen-
eration, and tumorigenesis, and thus the
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